Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population  

作　　者：Josh Bilson Christopher D.Byrne 

机构地区：[1]School of Human Development and Health,Faculty of Medicine,University of Southampton,Southampton,UK [2]National Institute for Health Research Southampton Biomedical Research Centre,University of Southampton and University Hospital Southampton National Health Service Foundation Trust,Southampton,UK

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第6期949-952,共4页肝胆外科与营养（英文）

基　　金：supported in part by the Southampton NIHR Biomedical Research Centre,UK (NIHR 203319).

摘　　要：Accumulating evidence in recent years has reinforced the notion that non-alcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease/metabolic dysfunction steatotic liver disease(NAFLD/MAFLD/MASLD)is a multisystem disease that increases the risk of all-cause and disease-specific mortality(1,2).

关 键 词：Fatty liver disease(FLD) non-alcoholic fatty liver disease(NAFLD) metabolic dysfunction steatotic liver disease(MASLD) metabolic dysfunction-associated fatty liver disease(MAFLD) mortality age ELDERLY older population 

分 类 号：R575.5[医药卫生—消化系统]